348 related articles for article (PubMed ID: 22196843)
1. The "obesity paradox": does it persist among Israeli patients with decompensated heart failure? A subanalysis of the Heart Failure Survey in Israel (HFSIS).
Schwartzenberg S; Benderly M; Malnick S; George J; Goland S
J Card Fail; 2012 Jan; 18(1):62-7. PubMed ID: 22196843
[TBL] [Abstract][Full Text] [Related]
2. The obesity paradox: body mass index and outcomes in patients with heart failure.
Curtis JP; Selter JG; Wang Y; Rathore SS; Jovin IS; Jadbabaie F; Kosiborod M; Portnay EL; Sokol SI; Bader F; Krumholz HM
Arch Intern Med; 2005 Jan; 165(1):55-61. PubMed ID: 15642875
[TBL] [Abstract][Full Text] [Related]
3. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry.
Fonarow GC; Srikanthan P; Costanzo MR; Cintron GB; Lopatin M;
Am Heart J; 2007 Jan; 153(1):74-81. PubMed ID: 17174642
[TBL] [Abstract][Full Text] [Related]
4. The obesity paradox in elderly patients with heart failure: analysis of nutritional status.
Casas-Vara A; Santolaria F; Fernández-Bereciartúa A; González-Reimers E; García-Ochoa A; Martínez-Riera A
Nutrition; 2012 Jun; 28(6):616-22. PubMed ID: 22261572
[TBL] [Abstract][Full Text] [Related]
5. Obesity as a prognostic factor in chronic symptomatic heart failure.
Bozkurt B; Deswal A
Am Heart J; 2005 Dec; 150(6):1233-9. PubMed ID: 16338264
[TBL] [Abstract][Full Text] [Related]
6. Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox.
Badheka AO; Rathod A; Kizilbash MA; Garg N; Mohamad T; Afonso L; Jacob S
Am J Med; 2010 Jul; 123(7):646-51. PubMed ID: 20609687
[TBL] [Abstract][Full Text] [Related]
7. Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox.
Shah R; Gayat E; Januzzi JL; Sato N; Cohen-Solal A; diSomma S; Fairman E; Harjola VP; Ishihara S; Lassus J; Maggioni A; Metra M; Mueller C; Mueller T; Parenica J; Pascual-Figal D; Peacock WF; Spinar J; van Kimmenade R; Mebazaa A;
J Am Coll Cardiol; 2014 Mar; 63(8):778-85. PubMed ID: 24315906
[TBL] [Abstract][Full Text] [Related]
8. Effect of obesity on in-hospital treatment for acute coronary syndrome complicated by new-onset heart failure.
Wu AH; Eagle KA; Froehlich JB; Montgomery DG; Kline-Rogers E; Aaronson KD
Coron Artery Dis; 2013 Jun; 24(4):279-84. PubMed ID: 23511946
[TBL] [Abstract][Full Text] [Related]
9. Obesity paradox in patients with hypertension and coronary artery disease.
Uretsky S; Messerli FH; Bangalore S; Champion A; Cooper-Dehoff RM; Zhou Q; Pepine CJ
Am J Med; 2007 Oct; 120(10):863-70. PubMed ID: 17904457
[TBL] [Abstract][Full Text] [Related]
10. B-type natriuretic peptide levels in obese patients with advanced heart failure.
Horwich TB; Hamilton MA; Fonarow GC
J Am Coll Cardiol; 2006 Jan; 47(1):85-90. PubMed ID: 16386669
[TBL] [Abstract][Full Text] [Related]
11. The paradox of obesity in patients with heart failure.
Hall JA; French TK; Rasmusson KD; Vesty JC; Roberts CA; Rimmasch HL; Kfoury AG; Renlund DG
J Am Acad Nurse Pract; 2005 Dec; 17(12):542-6. PubMed ID: 16293163
[TBL] [Abstract][Full Text] [Related]
12. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
13. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
[TBL] [Abstract][Full Text] [Related]
14. Relation of obesity to heart failure hospitalization and cardiovascular events in persons with stable coronary heart disease (from the Heart and Soul Study).
Spies C; Farzaneh-Far R; Na B; Kanaya A; Schiller NB; Whooley MA
Am J Cardiol; 2009 Oct; 104(7):883-9. PubMed ID: 19766751
[TBL] [Abstract][Full Text] [Related]
15. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
Shah R; Wang Y; Foody JM
Am J Cardiol; 2008 Jan; 101(2):217-22. PubMed ID: 18178410
[TBL] [Abstract][Full Text] [Related]
16. [Impact of overweight on clinical outcomes in patients undergoing coronary revascularization].
Kang JP; Ma CS; Lü Q; Nie SP; Liu XM; Liu XH; DU X; Hu R; Dong JZ; Chen F; Lü SZ; Gu CX; Huang FJ; Wu XS
Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1381-4. PubMed ID: 20646625
[TBL] [Abstract][Full Text] [Related]
17. Effect of body mass index on outcomes after cardiac surgery: is there an obesity paradox?
Stamou SC; Nussbaum M; Stiegel RM; Reames MK; Skipper ER; Robicsek F; Lobdell KW
Ann Thorac Surg; 2011 Jan; 91(1):42-7. PubMed ID: 21172483
[TBL] [Abstract][Full Text] [Related]
18. Is there any survival advantage of obesity in Southern European haemodialysis patients?
Chazot C; Gassia JP; Di Benedetto A; Cesare S; Ponce P; Marcelli D
Nephrol Dial Transplant; 2009 Sep; 24(9):2871-6. PubMed ID: 19369686
[TBL] [Abstract][Full Text] [Related]
19. [Does body mass index influence mortality in patients with heart failure?].
Zamora E; Lupón J; Urrutia A; González B; Mas D; Pascual T; Domingo M; Valle V
Rev Esp Cardiol; 2007 Nov; 60(11):1127-34. PubMed ID: 17996172
[TBL] [Abstract][Full Text] [Related]
20. Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy.
Olivotto I; Maron BJ; Tomberli B; Appelbaum E; Salton C; Haas TS; Gibson CM; Nistri S; Servettini E; Chan RH; Udelson JE; Lesser JR; Cecchi F; Manning WJ; Maron MS
J Am Coll Cardiol; 2013 Jul; 62(5):449-57. PubMed ID: 23643593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
